home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

217.99 -16.65 (-7.10%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

25 26 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

2 Top Biotech Stocks to Buy for the Long Haul ↗

December 25, 2022

These mid-cap biotechs are solid long-term choices.

Via The Motley Fool

Here's How Much $100 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth Today ↗

December 23, 2022

Via Benzinga

Got $5,000? 2 Unstoppable Stocks to Buy and Hold ↗

December 22, 2022

These businesses are growing and can be excellent places to make a sizable investment right now.

Via The Motley Fool

Better Buy: Moderna vs Axsome ↗

December 22, 2022

Revenue prospects look promising for both of these biotech companies.

Via The Motley Fool

The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗

December 18, 2022

Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.

Via InvestorPlace

If You Invested $100 In This Stock 5 Years Ago, You Would Have $1,500 Today ↗

December 07, 2022

Via Benzinga

Axsome Therapeutics Stock: Bear vs. Bull ↗

December 02, 2022

2023 will almost certainly see Axsome's top line explode higher.

Via The Motley Fool

Axsome Therapeutics's Return On Capital Employed Insights ↗

November 30, 2022

Via Benzinga

Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows. ↗

December 17, 2022

Stocks usually go down during recessions, but long-term investors can still come out on top.

Via The Motley Fool

After Jumping 100%, Is Axsome a Buy Before 2023? ↗

December 16, 2022

Axsome's revenue story is just getting started.

Via The Motley Fool

Is Anavex Life Sciences a Buy? ↗

December 13, 2022

It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.

Via The Motley Fool

Where to Invest $1,000 Before the End of 2022 ↗

December 13, 2022

Right now is the perfect time to put your money to work.

Via The Motley Fool

3 High-Flying Stocks to Buy and Hold If a Recession Is on the Way ↗

December 13, 2022

An economic downturn shouldn't hurt these stocks.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Analyst Ratings for Axsome Therapeutics ↗

November 29, 2022

Via Benzinga

These Were The Five Best And Worst Performing Mid-Cap Stocks In November 2022 ↗

December 11, 2022

In November, the Dow Jones gained around 7%, the S&P 500 gained 8.4%, and the Nasdaq gained 9.1%. The S&P Mid-Cap 400 performance was in line with major indices. Let’s take a look at the five best and...

Via Talk Markets

3 Red-Hot Stocks That Could Continue to Beat the Market ↗

December 11, 2022

The success these stocks achieved in 2022 could be just the beginning.

Via The Motley Fool

3 High-Flying Stocks in 2022 That Should Keep Soaring in 2023 ↗

December 10, 2022

These stocks' tailwinds should continue blowing in the new year.

Via The Motley Fool

3 Surefire Stocks to End 2022 on a Good Note ↗

December 10, 2022

These stocks should help your portfolio shine now and well into the future.

Via The Motley Fool

2 Unstoppable Growth Stocks to Buy in 2022 and Beyond ↗

December 08, 2022

These biotech players beat the bear market this year.

Via The Motley Fool

3 Fierce Stocks That Are Screaming Buys in December ↗

December 07, 2022

Here are three winners in the making.

Via The Motley Fool

Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022

December 07, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money ↗

December 07, 2022

There's no guarantee of 100% returns for these stocks, but their chances look pretty good.

Via The Motley Fool

12 Top Stocks to Buy in December ↗

December 03, 2022

Add this dandy dozen to your stocking this month.

Via The Motley Fool

Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review ↗

December 02, 2022

The S&P 500 is fighting for its 200-day, a critical level for the uptrend.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Struggling Axsome Stock Could Bounce Back on Drug Trial Success

November 30, 2022

Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.

Via MarketBeat

FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday ↗

November 29, 2022

Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...

Via Benzinga

Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

November 28, 2022

Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com